Ignite Creation Date:
2025-12-26 @ 11:13 AM
Ignite Modification Date:
2026-03-13 @ 5:35 AM
Study NCT ID:
NCT00667628
Status:
TERMINATED
Last Update Posted:
2024-09-19
First Post:
2008-04-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Study of TAC-101 Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone in Japanese Patients With Advanced Hepatocellular Carcinoma
Sponsor:
Taiho Oncology, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TAC101-203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |